Fig. 1From: A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)Survival analysis. Kaplan-Meyer curves for overall survival (a) and disease-free survival (b) are shownBack to article page